Compound information
- Natural Products
- ZC2036165
- Molecular Formula
- C15H13NO2
- Molecular Weight
- 239.094628656 g/mol
- Structure
-
- IUPAC Name
- N-(4-phenoxyphenyl)prop-2-enamide
- InChI
- InChI=1S/C15H13NO2/c1-2-15(17)16-12-8-10-14(11-9-12)18-13-6-4-3-5-7-13/h2-11H,1H2,(H,16,17)
- InChI Key
- MEKQGWMFJFNYOY-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(Oc2ccccc2)cc1
- Source
- ZINC000036334197
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 2 |
Heteroatom Count | 3 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 38.33 Å2 | LogP | 3.598 |
LogS | -4.423 | LogD | 3.548 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.043 | Pgp substrate | 0.125 |
HIA | 0.963 | F20 % | 0.989 |
F30 % | 0.25 | Caco-2 | -4.682 |
MDCK | -4.739 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.779 | PPB | 92.633 |
VD | 0.642 | Fu | 1.872 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.708 |
CYP2A6 substrate | 0.647 | CYP2B6 substrate | 0.586 |
CYP2C19 inhibitor | 0.947 | CYP2C19 substrate | 0.788 |
CYP2C8 substrate | 0.736 | CYP2C9 inhibitor | 0.575 |
CYP2C9 substrate | 0.067 | CYP2D6 inhibitor | 0.45 |
CYP2D6 substrate | 0.552 | CYP2E1 substrate | 0.876 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.823 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.589 | CL | 9.353 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.247 | Hepatotoxicity | 0.983 |
Mutagenicity | 0.924 | Rat Oral Acute Toxicity | 0.013 |
FDAMDD | 0.394 | Skin Sensitization | 0.998 |
Carcinogenicity | 0.669 | Eye Corrosion | 0.016 |
Eye Irritation | 0.927 | Respiratory Toxicity | 0.467 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 2.085 | IGC50 | 4.525 |
LC50FM | 5.725 | LC50DM | 5.452 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.246 | NR-AR-LBD | 0.224 |
NR-AhR | 0.847 | NR-Aromatase | 0.241 |
NR-ER | 0.856 | NR-ER-LBD | 0.575 |
NR-PPAR-gamma | 0.84 | SR-ARE | 0.923 |
SR-ATAD5 | 0.739 | SR-HSE | 0.376 |
SR-MMP | 0.855 | SR-p53 | 0.822 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.